Spots Global Cancer Trial Database for ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
Official Title: A Phase II Study of ONC201 in Recurrent or Metastatic Type II Endometrial Cancer
Study ID: NCT03485729
Conditions
Interventions
Study Description
Brief Summary: This is a a Simon's two-stage, non-randomized, open label, 2-arm Phase II trial of ONC201 in women with metastatic or recurrent Type II endometrial cancer who failed at least 1 prior chemotherapy regimen.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Rutgers, The State University of New Jersey, New Brunswick, New Jersey, United States
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
